Appendix 4C & Quarterly Business Update – March 2024
Genetic Technologies(GENE) Newsfilter·2024-04-30 12:00MELBOURNE, Australia, April 30, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in guideline-driven genomics-based testing in health, wellness and serious diseases, releases its Appendix 4C and Quarterly business update for the quarter ending 30 March 2024 (Q3 FY24). Key highlights: Cash Receipts totalling A$1.8m for the quarter ending March 2024.Launched targeted digital strategy for geneType CIT Sales in the United States, driving the highe ...